Janux Therapeutics (JANX) Amortizatization of Intangibles (2021 - 2026)

Janux Therapeutics (JANX) has 6 years of Amortizatization of Intangibles data on file, last reported at $2.6 million in Q1 2026.

• Quarterly Amortizatization of Intangibles fell 37.83% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.0 million (up 22.72% YoY) and the FY2025 annual result came in at $17.6 million, up 66.03% from the prior year.
• Amortizatization of Intangibles slipped to $2.6 million in Q1 2026 per JANX's latest filing, from $3.5 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $5.2 million in Q2 2025 and bottomed at $24000.0 in Q1 2022.
• The 5-year median for Amortizatization of Intangibles is $2.1 million (2023), against an average of $2.4 million.
• The widest annual swing landed in 2023, when Amortizatization of Intangibles soared 6891.67%; it then sank 37.83% in 2026.
• Tracing JANX's Amortizatization of Intangibles over 5 years: stood at $1.3 million in 2022, then jumped by 59.52% to $2.1 million in 2023, then surged by 42.02% to $2.9 million in 2024, then rose by 20.4% to $3.5 million in 2025, then slipped by 25.54% to $2.6 million in 2026.
• Per Business Quant, the three latest JANX Amortizatization of Intangibles figures stand at $2.6 million (Q1 2026), $3.5 million (Q4 2025), and $4.6 million (Q3 2025).

Peer Comparison